Alpha Teknova (TKNO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for June 17, 2025, to elect two Class I directors and ratify the appointment of Grant Thornton LLP as the independent auditor for 2025.
Only stockholders of record as of April 22, 2025, are entitled to vote; 53,440,810 shares are outstanding.
Proxy materials are provided online to reduce costs and environmental impact.
Voting matters and shareholder proposals
Proposals include electing Martha J. Demski and Alexander Herzick as Class I directors and ratifying Grant Thornton LLP as auditor.
Board recommends voting FOR both proposals.
Shareholders may submit proposals for the 2026 meeting by December 29, 2025, and director nominations between February 17 and March 19, 2026.
Board of directors and corporate governance
Board consists of eight directors divided into three staggered classes; only three are independent under Nasdaq rules.
Board leadership is split between CEO Stephen Gunstream and Chairman Paul Grossman.
The company is a "controlled company" under Nasdaq rules, allowing exemptions from certain governance requirements.
Committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and responsibilities.
Board and committees met regularly in 2024, with all directors attending at least 75% of meetings.
Latest events from Alpha Teknova
- 2025 revenue rose 7% to $40.5M, with margin gains and improved cash flow; 2026 outlook positive.TKNO
Q4 202527 Feb 2026 - Growth driven by custom manufacturing, new products, and a path to profitability at $50M+ revenue.TKNO
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Q2 revenue up sequentially, net loss narrowed, and liquidity improved after $15.4M equity raise.TKNO
Q2 20241 Feb 2026 - Q3 revenue up 17% year-over-year, net loss narrows, and liquidity strengthened by $15M+ raise.TKNO
Q3 202415 Jan 2026 - Stabilized demand, new flexible offerings, and cost discipline set the stage for future growth.TKNO
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - 2024 revenue up 3% to $37.7M, Q4 up 18%, with improved margins and cash flow.TKNO
Q4 202424 Dec 2025 - Registering up to $225M in securities to fund growth in high-growth life sciences markets.TKNO
Registration Filing16 Dec 2025 - Annual meeting to elect directors and ratify auditor, with online proxy access and voting.TKNO
Proxy Filing2 Dec 2025 - 12.4M shares registered for resale after private placement; no proceeds to company.TKNO
Registration Filing29 Nov 2025